NCT05266898
- Conditions
- Acquired Immunodeficiency Syndrome, Anal Intraepithelial Neoplasia, Blood-Borne Infections, +34 more
- Locations
-
- University Medical Center New Orleans New Orleans, Louisiana, United States
Clinical trial condition
Anal Intraepithelial Neoplasia
Explore clinical trials studying Anal Intraepithelial Neoplasia. Study availability and eligibility vary by location and protocol.
8 public trials
1 recruiting study
Anal Intraepithelial Neoplasia trial results
NCT06233331
- Conditions
- Acquired Immunodeficiency Syndrome, Anal Intraepithelial Neoplasia, Blood-Borne Infections, +20 more
- Locations
-
- Grady Memorial Hospital Atlanta, Georgia, United States
Completed
VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions
NCT03603808
- Conditions
- Anal Intraepithelial Neoplasia, Blood-Borne Infections, Communicable Diseases, +20 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Grady Health System Atlanta, Georgia, United States
- Anal Dysplasia Clinic MidWest Chicago, Illinois, United States
- Boston Medical Center Boston, Massachusetts, United States
NCT02059499
- Conditions
- Anal Intraepithelial Neoplasia, Blood-Borne Infections, Communicable Diseases, +17 more
- Locations
-
- UCLA CARE Center Los Angeles, California, United States
- UCSF-Mount Zion San Francisco, California, United States
- University of California, San Francisco San Francisco, California, United States
- Emory University Atlanta, Georgia, United States
Completed
Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)
NCT01651949
- Conditions
- Anal Cancer, Anal Intraepithelial Neoplasia, Anus Diseases, +32 more
- Locations
-
Not specified
NCT01923116
- Conditions
- Anal Intraepithelial Neoplasia, HIV
- Locations
-
- Academic Medical Center Amsterdam, North Holland, Netherlands
NCT01637298
- Conditions
- Anal Intraepithelial Neoplasia, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
Not specified
Active, Not Recruiting
A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males
NCT06866574
- Conditions
- Anal Cancer, Anal Intraepithelial Neoplasia, Anus Diseases, +34 more
- Locations
-
- Fujian Provincial Center for Disease Control and Prevention Fuzhou, Fujian, China
- Sichuan Provincial Center for Disease Control and Prevention Chengdu, Sichuan, China
- Yunnan Provincial Center for Disease Control and Prevention Kunming, Yunnan, China
- Zhejiang Provincial Center for Disease Control and Prevention Hangzhou, Zhejiang, China